Cite
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA‐REG OUTCOME trial.
MLA
Ferreira, João Pedro, et al. “Empagliflozin and Uric Acid Metabolism in Diabetes: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial.” Diabetes, Obesity & Metabolism, vol. 24, no. 1, Jan. 2022, pp. 135–41. EBSCOhost, https://doi.org/10.1111/dom.14559.
APA
Ferreira, J. P., Inzucchi, S. E., Mattheus, M., Meinicke, T., Steubl, D., Wanner, C., & Zinman, B. (2022). Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA‐REG OUTCOME trial. Diabetes, Obesity & Metabolism, 24(1), 135–141. https://doi.org/10.1111/dom.14559
Chicago
Ferreira, João Pedro, Silvio E. Inzucchi, Michaela Mattheus, Thomas Meinicke, Dominik Steubl, Christoph Wanner, and Bernard Zinman. 2022. “Empagliflozin and Uric Acid Metabolism in Diabetes: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial.” Diabetes, Obesity & Metabolism 24 (1): 135–41. doi:10.1111/dom.14559.